AU Stock MarketDetailed Quotes
HLS Healius Ltd
- 1.150
- +0.050+4.55%
20min DelayMarket Closed May 3 16:00 AET
835.01MMarket Cap-1926P/E (Static)
1.155High1.090Low3.99MVolume1.100Open1.100Pre Close4.55MTurnover3.26552wk High0.61%Turnover Ratio726.10MShares1.08052wk Low-1.621EPS TTM747.72MFloat Cap8.426Historical HighLossP/E (Static)650.19MShs Float0.581Historical Low-0.597EPS LYR5.91%Amplitude--Dividend TTM0.79P/B1Lot Size--Div YieldTTM
About Healius Ltd Company
Healius is Australia’s second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.
Company Profile
SymbolHLS
Company NameHealius Ltd
Founded1994
MarketASX
Employees10500
Fiscal Year Ends06-30
Address161 Castlereagh Street Level 22
CitySydney
CountryAustralia
Zip Code2000
Phone+61 294329400
Websitehttps://www.healius.com.au
Company Executives
- Name
- Position
- Salary
- Maxine Jaquet
- Director, Managing Director and Chief Executive Officer
- --
- Jenny Macdonald, B.Com
- Non-Executive Chairman of the Board
- --
- Charlie Taylor
- Director
- --
- Professor John Mattick, A.O.
- Independent Director
- --
- Gordon Davis, M.B.A.
- Independent Director
- --
- Kate Mckenzie, B.A.,L.L.B.,M.A.I.C.D.
- Independent Director
- --
- Sally Evans
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg